2013 American Transplant Congress

May 18-22, 2013 in Seattle, Washington

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Antithymocytes Globulines and Immune Senescence in Renal Transplant Patients

J. Bamoulid, C. Roubiou, T. Crépin, B. Gaugler, P. Tiberghien, C. Ferrand, J. Chalopin, P. Saas, D. Ducloux
Antiviral Prophylaxis for HBsAg-Positive Renal Transplant Recipients Treated with Rituximab®

Y. Kim, Y. Han, J. Jung, H. Cho, Y. Lim, S. Park, D. Han
APOL1 and MHY9 Gene Variants and Allograft Outcomes in Kidney Transplantation

A. Israni, W. Guan, D. Schladt, W. Oetting, P. Jacobson, A. Matas, for DEKAF Genomics Study
Application of Rejection Reversal as Defined by Efficacy Endpoints in Present Day Renal Transplantation

A. Jantz, S. Patel, L. Moore, R. Knight, A. Gaber
Arachidonate Lipoxygenase Controls the Suppressive Function of Myeloid Derived Suppressor Cells

M. Burns, J. Ochando
Are Preemptive Deceased Donor Kidney Transplants Equitable?

A. Agunbiade, J. Thistlethwaite, Jr, L. Ross
Are Some “High-Risk” Renal Transplants Recipients Higher Risk Than Others?

S. Patel, J. DeVos, R. Knight, A. Gaber
Arterial Stiffness in Kidney Transplantation: Relationship with Dipper Status on Ambulatory Blood Pressure Monitoring

E. Melilli, M. Melibeo, O. Bestard, I. Rivas, J. Cruzado, J. Grinyó
Arteriosclerosis in Histological Evaluations Using Zero-Time Biopsy Is a Risk Factor for Tacrolimus-Induced Nephrotoxicity

T. Yagisawa, K. Omoto, T. Shimizu, T. Nozaki, H. Ishida, K. Honda, J. Koike, K. Tanabe
Assessing Cell Mediated Immunity (CMI) Status by the ImmuKnow Assay in Renal Transplant Recipients

H. Xiang, W. Xue, P. Tian, X. Ding, X. Pan, H. Yan, J. Hou, X. Feng, X. Tian, C. Ding

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z